Systemic lupus erythematosus (SLE) is a chronic multisystem auto-immune disease with extremely varied clinical manifestations and a complex pathogenesis. New insights in SLE about pathogenetic pathways, biomarkers, and data on clinical manifestations are progressively emerging, and new drugs and new therapeutic strategies have been proposed to improve the control of disease activity. Thus, this review is aimed to summarise the most relevant data about SLE emerged during 2021, following the previous annual review of this series.

One year in review 2022: systemic lupus erythematosus

Bortoluzzi, Alessandra
Penultimo
;
2022

Abstract

Systemic lupus erythematosus (SLE) is a chronic multisystem auto-immune disease with extremely varied clinical manifestations and a complex pathogenesis. New insights in SLE about pathogenetic pathways, biomarkers, and data on clinical manifestations are progressively emerging, and new drugs and new therapeutic strategies have been proposed to improve the control of disease activity. Thus, this review is aimed to summarise the most relevant data about SLE emerged during 2021, following the previous annual review of this series.
2022
Zucchi, Dina; Elefante, Elena; Schilirò, Davide; Signorini, Viola; Trentin, Francesca; Bortoluzzi, Alessandra; Tani, Chiara
File in questo prodotto:
File Dimensione Formato  
11392-2501243.pdf

accesso aperto

Descrizione: versione editoriale
Tipologia: Full text (versione editoriale)
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 391.47 kB
Formato Adobe PDF
391.47 kB Adobe PDF Visualizza/Apri

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2501243
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 51
  • ???jsp.display-item.citation.isi??? 49
social impact